Related references
Note: Only part of the references are listed.PTEN-mediated pathways and their association with treatment-resistant prostate cancer
Christopher C. Uzoh et al.
BJU INTERNATIONAL (2009)
Mutations and Response to Epidermal Growth Factor Receptor Inhibitors
Pierre Laurent-Puig et al.
CLINICAL CANCER RESEARCH (2009)
Targeting the PI3K/AKT Pathway for the Treatment of Prostate Cancer
Debashis Sarker et al.
CLINICAL CANCER RESEARCH (2009)
Impact of EGFR mutation analysis in non-small cell lung cancer
Hiromasa Yamamoto et al.
LUNG CANCER (2009)
PI3K/PTEN signaling in tumorigenesis and angiogenesis
Bing-Hua Jiang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2008)
Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations
C. Q. Cai et al.
ONCOGENE (2008)
Temporally controlled ablation of PTEN in adult mouse prostate epithelium generates a model of invasive prostatic adenocarcinoma
Chandrahas Kouimar Ratnacaram et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Gene amplification and mutation analysis of epidermal growth factor receptor in hormone refractory prostate cancer
Kang Su Cho et al.
PROSTATE (2008)
Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer
Tetsuya Mitsudomi et al.
CANCER SCIENCE (2007)
PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis
Jing Fang et al.
CELLULAR SIGNALLING (2007)
Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer
Thorsten Schlomm et al.
CLINICAL CANCER RESEARCH (2007)
The epidermal growth factor receptor: from development to tumorigenesis
Maria Sibilia et al.
DIFFERENTIATION (2007)
FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome
M. Yoshimoto et al.
BRITISH JOURNAL OF CANCER (2007)
Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplilications, and KRAS mutations on survival of pancreatic adenocarcinoma
Jeeyun Lee et al.
CANCER (2007)
Complete loss of PTEN expression as a possible early prognostic marker for prostate cancer metastasis
Martine Schmitz et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Somatic mutations of the epidermal growth factor receptor and non-small-cell lung cancer
Xiaozhu Zhang et al.
JOURNAL OF MEDICAL GENETICS (2007)
Epidermal growth factor receptor mutations in lung cancer
Sreenath V. Sharma et al.
NATURE REVIEWS CANCER (2007)
Mechanisms of egfr gene transcription modulation:: Relationship to cancer risk and therapy response
Burkhard Brandt et al.
CLINICAL CANCER RESEARCH (2006)
Comprehensive assessment of DNA copy number alterations in human prostate cancers using Affymetrix 100K SNP mapping array
Wennuan Liu et al.
GENES CHROMOSOMES & CANCER (2006)
PTEN function in normal and neoplastic growth
Lionel M. L. Chow et al.
CANCER LETTERS (2006)
Novel mutations of epidermal growth factor receptor in localized prostate cancer
Diah A. Douglas et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Effect of epidermal growth factor receptor tyrosine kinase domain mutations on the outcome of patients with non-small cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors
Pasi A. Jaenne et al.
CLINICAL CANCER RESEARCH (2006)
Epidermal growth factor receptor kinase domain mutations in esophageal and pancreatic adenocarcinomas
Eunice L. Kwak et al.
CLINICAL CANCER RESEARCH (2006)
Prevalent mutations in prostate cancer
JT Dong
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Epidermal growth factor receptor (EGFR) signaling in cancer
N Normanno et al.
GENE (2006)
High frequency of submicroscopic hemizygous deletion is a major mechanism of loss of expression of PTEN in uveal melanoma
MH Abdel-Rahman et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Akt-regulated pathways in prostate cancer
PK Majumder et al.
ONCOGENE (2005)
Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck
JW Lee et al.
CLINICAL CANCER RESEARCH (2005)
Somatic mutations of epidermal growth factor receptor in colorectal carcinoma
H Nagahara et al.
CLINICAL CANCER RESEARCH (2005)
Expression patterns of potential therapeutic targets in prostate cancer
T Zellweger et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Human cancer, PTEN and the PI-3 kinase pathway
R Parsons
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2004)
Racial disparity of epidermal growth factor receptor expression in prostate cancer
B Shuch et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Role of PI3K/AKT/mTOR signaling in the cell cycle progression of human prostate cancer
N Gao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression
B Kwabi-Addo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
The multiple roles of PTEN in tumor suppression
A Di Cristofano et al.
CELL (2000)
Share Paper
